Interleukin-6 stimulates defective angiogenesis

G Gopinathan, C Milagre, OMT Pearce, LE Reynolds… - Cancer research, 2015 - AACR
The cytokine IL6 has a number of tumor-promoting activities in human and experimental
cancers, but its potential as an angiogenic agent has not been fully investigated. Here, we …
被引用次数：246 相关文章

Interleukin-6 Stimulates Defective Angiogenesis.

G Gopinathan, C Milagre, OM Pearce… - Cancer …, 2015 - europepmc.org
Abstract The cytokine interleukin-6 (IL-6) has a number of tumor-promoting activities in
human and experimental cancers, but its potential as an angiogenic agent has not been fully …

Interleukin-6 Stimulates Defective Angiogenesis

G Gopinathan, C Milagre, OMT Pearce, LE Reynolds… - Cancer …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The cytokine IL6 has a number of tumor-
promoting activities in human and experimental cancers, but its potential as an angiogenic …

Interleukin-6 Stimulates Defective Angiogenesis

G Gopinathan, C Milagre, OMT Pearce… - Cancer …, 2015 - pubmed.ncbi.nlm.nih.gov
The cytokine IL6 has a number of tumor-promoting activities in human and experimental
cancers, but its potential as an angiogenic agent has not been fully investigated. Here, we …

Interleukin–6 stimulates defective angiogenesis

G Gopinathan, C Milagre, OMT Pearce, L Reynolds… - Cancer Research, 2015 - AACR
The aim of this study was to investigate the effects of IL-6 in normal and tumour
angiogenesis. In previous studies we found that elevated levels of the inflammatory cytokine …
[HTML] nih.gov

[HTML][HTML] Interleukin-6 stimulates defective angiogenesis

G Gopinathan, C Milagre, OMT Pearce… - Cancer …, 2015 - ncbi.nlm.nih.gov
Abstract The cytokine interleukin-6 (IL-6) has a number of tumor-promoting activities in
human and experimental cancers, but its potential as an angiogenic agent has not been fully …

Interleukin-6 Stimulates Defective Angiogenesis.

G Gopinathan, C Milagre, OM Pearce… - Cancer …, 2015 - europepmc.org
Abstract The cytokine interleukin-6 (IL-6) has a number of tumor-promoting activities in
human and experimental cancers, but its potential as an angiogenic agent has not been fully …